Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DALFAMPRIDINE
- Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis
- Effects of Physical Therapy and Dalfampridine on Functional Mobility in Non Ambulatory Persons With Multiple Sclerosis
- Dalfampridine in Egyptian Patients With Multiple Sclerosis
- The Effect of Dalfampridine in Hereditary Spastic Paraparezi: Randomized Controlled Trial
- Effects of 4-AP on Functional SCI Recovery
- A Single Dose Pharmaco-Diagnostic for Peripheral Nerve Continuity After Trauma
- Use of Dalfampridine in Primary Lateral Sclerosis
- Effect of Dalfampridine (4-AP) on Genioglossus Muscle Activity in Healthy Adults
- Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
- Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis
- A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets.
- Efficacy of Dalfampridine on Upper Extremity Function in Patients With MS
- Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
- Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)
- Effects of Dalfampridine on Cognition in Multiple Sclerosis
- A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
- A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis
- Dalfampridine and Gait in Spinocerebellar Ataxias
- Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients
- Combination Therapy With Dalfampridine and Locomotor Training for Chronic, Motor Incomplete Spinal Cord Injury
- A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
- 4-Aminopyridine in Episodic Ataxia Type 2
- A Randomized Trial to Evaluate Ampyra for Gait Impairment in Parkinson's Disease
- Open-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple Sclerosis
- An Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra (BIIB041) When Used In Routine Medical Practice
- Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy
- Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)
- Dalfampridine for Imbalance in Multiple Sclerosis
- A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis
- Ampyra for Optic Neuritis in Multiple Sclerosis
- Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis
- Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal Impairment
- Open Label Extension Study to Evaluate the Safety and Tolerability of Oral Fampridine-Sustained Release (SR) in Canadian Participants With Multiple Sclerosis Who Participated in Acorda Extension Trials.
- A Pharmacokinetics (PK) and Safety Study of Oral Fampridine-PR 10 mg in Chinese, Japanese, and Caucasian Adult Healthy Volunteers
Clinical trials list
click for details